Moexipril Hydrochloride丨CAS 82586-52-5

Moexipril Hydrochloride丨CAS 82586-52-5
Product Introduction:
Catalog No.: SS129409
CAS No.: 82586-52-5
Purity(HPLC): 98.0%min.
Product Name: Moexipril hydrochloride
Molecular Formula: C27H34N2O7.HCl
Molecular Weight: 535.03
Synonym(s): Moexipril HCL
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of moexipril hydrochloride丨cas 82586-52-5 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications of Moexipril hydrochloride丨CAS 82586-52-5

 

Appearance

White to off-white crystalline powder

Purity (HPLC)

98.0% min

Specific Rotation

+32 to +36°

Loss on Drying

1.0% max

Residue on Ignition

0.1% max

Heavy Metals

0.001% max

 

Transport Information of Moexipril hydrochloride丨CAS 82586-52-5

 

Parameter

Specification

UN Number

3077

Class

 

Packing Group

III

H.S. Code

2933490090304

Stability & Reactivity

The product is chemically stable under standard ambient conditions.

Storage

Tightly closed. Dry. Recommended storage temperature 2 - 8 °C

Condition to Avoid

 

Package

 

 

Manufacturing Information of Moexipril hydrochloride丨CAS 82586-52-5

 

Parameter

Specification

Capacity

500kg/month

Frequency

 

Main Export Countries

 

Capacity/Batch

 

Experience

Production since 2015

Stock

 

 

 

 

Overview

Moexipril hydrochloride丨CAS 82586-52-5 is an angiotensin-converting enzyme (ACE) inhibitor used primarily as an antihypertensive agent. It is a prodrug, meaning it is activated in the liver into its active metabolite moexiprilat, which inhibits the enzyme responsible for converting angiotensin I into angiotensin II-a potent vasoconstrictor.


 

Applications

1. Treatment of Hypertension

Lowers blood pressure by relaxing blood vessels.

Effective in monotherapy or in combination with other antihypertensive agents (e.g., diuretics, calcium channel blockers).

2. Management of Heart Failure

Reduces afterload and preload by vasodilation, enhancing cardiac output and relieving symptoms of heart failure.

3. Prevention of Diabetic Nephropathy

May delay the progression of kidney damage in diabetic patients by lowering intraglomerular pressure and reducing proteinuria.

4. Post-Myocardial Infarction Support

Helps reduce the risk of subsequent cardiovascular events by minimizing ventricular remodeling.


Mechanism of Action

Moexipril is hydrolyzed in the liver to moexiprilat.

Moexiprilat inhibits ACE, which reduces the conversion of angiotensin I to angiotensin II.

This results in vasodilation, decreased aldosterone secretion, reduced sodium retention, and lower blood pressure.


 

Benefits

✅ Long Duration of Action

Once-daily dosing is typically sufficient, improving patient compliance.

✅ Kidney-Protective Effects

Especially valuable in diabetic or hypertensive patients at risk of renal impairment.

✅ Minimal Impact on Heart Rate

Does not cause reflex tachycardia, a common side effect of other antihypertensives.

✅ Well-Tolerated

Most side effects (such as dry cough or dizziness) are mild and manageable.


 

Summary

Moexipril hydrochloride丨CAS 82586-52-5 is a prodrug ACE inhibitor used for controlling high blood pressure and managing heart-related conditions. Its high efficacy, long half-life, and renal protective properties make it a key choice in antihypertensive therapy, particularly for patients with comorbid cardiovascular or renal concerns.

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us